Mesoblast Ltd - ADR has a share price target of US$ 27, revenue growth forecast of 251.7%, and profit growth estimate of 15.9% for FY25, based on top 3 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature